{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T10:54:58Z","timestamp":1795172098916,"version":"4.10.3"},"reference-count":288,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"General Project of National Natural Science Foundation of China","award":["82274095"],"award-info":[{"award-number":["82274095"]}]},{"name":"Shaanxi Provincial Department of Science and Technology Key R&D Program Project","award":["2022SF-355"],"award-info":[{"award-number":["2022SF-355"]}]},{"name":"Shaanxi Provincial Key Industry Innovation Chain Project","award":["2022ZDLSF05-09"],"award-info":[{"award-number":["2022ZDLSF05-09"]}]},{"name":"Shaanxi Provincial Administration of Traditional Chinese Medicine Research Project","award":["2021-ZZ-ZY005"],"award-info":[{"award-number":["2021-ZZ-ZY005"]}]},{"name":"Shaanxi Provincial Department of Education Youth Innovation Team Project","award":["22JP005"],"award-info":[{"award-number":["22JP005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetes, a chronic metabolic non-communicable disease, has become prevalent worldwide. Its prevalence is increasing at an alarming rate, and the affected population is becoming increasingly younger, posing a serious threat to both individual health and social well-being. Notably, type 2 diabetes mellitus (T2DM) accounts for more than 90% of all diabetes cases, a statistic that underscores its dominant position in the disease burden. Despite substantial progress in the field of diabetes treatment, existing diabetes medications still fail to fully address the complex and pressing clinical needs of patients. Therefore, the development of new therapeutic drugs for T2DM is of crucial significance. Traditional Chinese medicine (TCM) has shown significant potential in alleviating the symptoms of T2DM and improving patients' quality of life, providing an effective complementary approach to conventional treatments. This study systematically clarifies and reviews the pathogenesis of T2DM from multiple dimensions, including inflammation, oxidative stress, ferroptosis, pyroptosis, necroptosis, autophagy, and gut microbiota. It also examines and summarizes TCM compound formulations and their main active ingredients that can improve the disease, and elucidates the disease-improving effects of these TCM ingredients targeting the aforementioned mechanisms. Studies have shown that TCM plays an important role in improving T2DM by targeting key mechanisms such as insulin resistance, \u03b2-cell damage, and glucose-lipid metabolism disorders. This not only provides valuable ideas and reference basis for researchers in endocrine basic research, pharmacologists, and clinicians to develop TCM with low toxicity and side effects but also opens up new research directions for the treatment of T2DM and lays a theoretical foundation for new drug development.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13020-025-01222-x","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:02:11Z","timestamp":1759532531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Therapeutic potential of traditional Chinese medicine and mechanisms for the treatment of type 2 diabetes mellitus"],"prefix":"10.1186","volume":"20","author":[{"given":"Miao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangzhuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"key":"1222_CR1","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3390\/molecules28073001","volume":"28","author":"G Yi","year":"2023","unstructured":"Yi G, Sang X, Zhu Y, Zhou D, Yang S, Huo Y, et al. The SWGEDWGEIW from soybean peptides reduces insulin resistance in 3T3-L1 adipocytes by activating p-Akt\/GLUT4 signaling pathway. Molecules. 2023;28:3001.","journal-title":"Molecules"},{"key":"1222_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/rej.2019.2228","volume":"23","author":"M Wang","year":"2020","unstructured":"Wang M, Chang SQ, Tian YS, Zhang GQ, Qi J. Zengye decoction ameliorates insulin resistance by promoting glucose uptake. Rejuvenation Res. 2020;23:367\u201376.","journal-title":"Rejuvenation Res"},{"key":"1222_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107841","volume":"157","author":"L Yuen","year":"2019","unstructured":"Yuen L, Saeedi P, Riaz M, Karuranga S, Divakar H, Levitt N, et al. Projections of the prevalence of hyperglycaemia in pregnancy in 2019 and beyond: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107841.","journal-title":"Diabetes Res Clin Pract"},{"key":"1222_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.829565","volume":"13","author":"LM Li","year":"2022","unstructured":"Li LM, Jiang BG, Sun LL. HNF1A: From monogenic diabetes to type 2 diabetes and gestational diabetes mellitus. Front Endocrinol. 2022;13:829565.","journal-title":"Front Endocrinol"},{"key":"1222_CR5","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.3390\/ijms25042338","volume":"25","author":"T Vilari\u00f1o-Garc\u00eda","year":"2024","unstructured":"Vilari\u00f1o-Garc\u00eda T, Polonio-Gonz\u00e1lez M, P\u00e9rez-P\u00e9rez A, Ribalta J, Arrieta F, Aguilar M, et al. Role of leptin in obesity, cardiovascular disease, and type 2 diabetes. Int J Mol Sci. 2024;25:2338.","journal-title":"Int J Mol Sci"},{"key":"1222_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46:15\u201337.","journal-title":"Diabetes Metab J"},{"key":"1222_CR7","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.2174\/0929867325666171205145309","volume":"25","author":"JB Popovic-Djordjevic","year":"2018","unstructured":"Popovic-Djordjevic JB, Jevtic II, Stanojkovic TP. Antidiabetics: structural diversity of molecules with a common aim. Curr Med Chem. 2018;25:2140\u201365.","journal-title":"Curr Med Chem"},{"key":"1222_CR8","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1007\/s00125-023-05956-x","volume":"66","author":"MA Nauck","year":"2023","unstructured":"Nauck MA, M\u00fcller TD. Incretin hormones and type 2 diabetes. Diabetologia. 2023;66:1780\u201395.","journal-title":"Diabetologia"},{"key":"1222_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00178","volume":"11","author":"MP Gilbert","year":"2020","unstructured":"Gilbert MP, Pratley RE. GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials. Front Endocrinol. 2020;11:178.","journal-title":"Front Endocrinol"},{"key":"1222_CR10","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2147\/DMSO.S517874","volume":"18","author":"S Wen","year":"2025","unstructured":"Wen S, Zhang H, Huang X, Wang C, Dong M, Wang C, et al. The therapeutic effect and mechanism of traditional Chinese medicine in type 2 diabetes mellitus and its complications. Diabet Metab Syndr Obes. 2025;18:1599\u2013627.","journal-title":"Diabet Metab Syndr Obes"},{"key":"1222_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1373711","volume":"15","author":"Y Feng","year":"2024","unstructured":"Feng Y, Ren Y, Zhang X, Yang S, Jiao Q, Li Q, et al. Metabolites of traditional Chinese medicine targeting PI3K\/AKT signaling pathway for hypoglycemic effect in type 2 diabetes. Front Pharmacol. 2024;15:1373711.","journal-title":"Front Pharmacol"},{"key":"1222_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1378140","volume":"15","author":"Y Xing","year":"2024","unstructured":"Xing Y, Li P, Pang G, Zhao H, Wen T. Observational study on stability of within-day glycemic variability of type 2 diabetes inpatients treated with decoctions of traditional Chinese medicine. Front Pharmacol. 2024;15:1378140.","journal-title":"Front Pharmacol"},{"key":"1222_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13020-020-00331-z","volume":"15","author":"S Chang","year":"2020","unstructured":"Chang S, Wang M, Tian Y, Qi J, Qiu Z. Systematic analysis and identification of the absorption and metabolic components of Zengye decoction in type 2 diabetic rats by HPLC-ESI-Q-TOF-MS\/MS. Chin Med. 2020;15:50.","journal-title":"Chin Med"},{"key":"1222_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1429360","volume":"15","author":"J Xu","year":"2024","unstructured":"Xu J, Zou Z, Li X, Sun X, Wang X, Qin F, et al. Effect of Gegen Qinlian decoction on the regulation of gut microbiota and metabolites in type II diabetic rats. Front Microbiol. 2024;15:1429360.","journal-title":"Front Microbiol"},{"key":"1222_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109564","volume":"121","author":"W Zheng","year":"2020","unstructured":"Zheng W, Wang G, Zhang Z, Wang Z, Ma K. Research progress on classical traditional Chinese medicine formula Liuwei Dihuang pills in the treatment of type 2 diabetes. Biomed Pharmacother. 2020;121:109564.","journal-title":"Biomed Pharmacother"},{"key":"1222_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117931","volume":"327","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhang S, Zhang Y, Wang H, Chen Y, Lu H. Activation of NRF2 by epiberberine improves oxidative stress and insulin resistance in T2DM mice and IR-HepG2 cells in an AMPK dependent manner. J Ethnopharmacol. 2024;327:117931.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR17","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3390\/nu12102954","volume":"12","author":"D Li","year":"2020","unstructured":"Li D, Jiang C, Mei G, Zhao Y, Chen L, Liu J, et al. Quercetin alleviates ferroptosis of pancreatic \u03b2 Cells in Type 2 diabetes. Nutrients. 2020;12:2954.","journal-title":"Nutrients"},{"key":"1222_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-019-04925-1","author":"T Liang","year":"2019","unstructured":"Liang T, Xu X, Ye D, Chen W, Gao B, Huang Y. Caspase\/AIF\/apoptosis pathway: a new target of puerarin for diabetes mellitus therapy. Mol Biol Rep. 2019. https:\/\/doi.org\/10.1007\/s11033-019-04925-1.","journal-title":"Mol Biol Rep"},{"key":"1222_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1222_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S2213-8587(24)00127-X","volume":"12","author":"M Abdul-Ghani","year":"2024","unstructured":"Abdul-Ghani M, Maffei P, DeFronzo RA. Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes. Lancet Diabet Endocrinol. 2024;12:674\u201380.","journal-title":"Lancet Diabet Endocrinol"},{"key":"1222_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00109-018-1623-z","volume":"96","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, Shankar K, Beg M, Rajan S, Gupta A, Varshney S, et al. Chronic hyperinsulinemia induced miR-27b is linked to adipocyte insulin resistance by targeting insulin receptor. J Mol Med (Berl). 2018;96:315\u201331.","journal-title":"J Mol Med (Berl)"},{"key":"1222_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1042\/BST20221066","volume":"51","author":"J van Gerwen","year":"2023","unstructured":"van Gerwen J, Shun-Shion AS, Fazakerley DJ. Insulin signalling and GLUT4 trafficking in insulin resistance. Biochem Soc Trans. 2023;51:1057\u201369.","journal-title":"Biochem Soc Trans"},{"key":"1222_CR23","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1007\/s00018-016-2259-1","volume":"73","author":"SR Barthel","year":"2016","unstructured":"Barthel SR, Medvedev R, Heinrich T, B\u00fcchner SM, Kettern N, Hildt E. Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor. Cell Mol Life Sci. 2016;73:4121\u201340.","journal-title":"Cell Mol Life Sci"},{"key":"1222_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.699","volume":"12","author":"W Liao","year":"2022","unstructured":"Liao W, Xu N, Zhang H, Liao W, Wang Y, Wang S, et al. Persistent high glucose induced EPB41L4A-AS1 inhibits glucose uptake via GCN5 mediating crotonylation and acetylation of histones and non-histones. Clin Transl Med. 2022;12:e699.","journal-title":"Clin Transl Med"},{"key":"1222_CR25","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/molecules26072101","volume":"26","author":"S Jayaraman","year":"2021","unstructured":"Jayaraman S, Devarajan N, Rajagopal P, Babu S, Ganesan SK, Veeraraghavan VP, et al. \u03b2-sitosterol circumvents obesity induced inflammation and insulin resistance by down-regulating IKK\u03b2\/NF-\u03baB and JNK signaling pathway in adipocytes of Type 2 Diabetic Rats. Molecules. 2021;26:2101.","journal-title":"Molecules"},{"key":"1222_CR26","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1111\/febs.15020","volume":"286","author":"L Liu","year":"2019","unstructured":"Liu L, Liang C, Mei P, Zhu H, Hou M, Yu C, et al. Dracorhodin perchlorate protects pancreatic \u03b2-cells against glucotoxicity- or lipotoxicity-induced dysfunction and apoptosis in vitro and in vivo. FEBS J. 2019;286:3718\u201336.","journal-title":"FEBS J"},{"key":"1222_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00157","volume":"7","author":"I Ray","year":"2016","unstructured":"Ray I, Mahata SK, De RK. Obesity: an immunometabolic perspective. Front Endocrinol. 2016;7:157.","journal-title":"Front Endocrinol"},{"key":"1222_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature21365","volume":"542","author":"T Thomou","year":"2017","unstructured":"Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542:450\u20135.","journal-title":"Nature"},{"key":"1222_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11596-024-2902-2","volume":"44","author":"R He","year":"2024","unstructured":"He R, Chen Y. The role of adipose tissue-derived exosomes in chronic metabolic disorders. Curr Med Sci. 2024;44:463\u201374.","journal-title":"Curr Med Sci"},{"key":"1222_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1142\/S0192415X19500058","volume":"47","author":"X Shi","year":"2019","unstructured":"Shi X, Wang S, Luan H, Tuerhong D, Lin Y, Liang J, et al. Clinopodium chinense attenuates palmitic acid-induced vascular endothelial inflammation and insulin resistance through TLR4-mediated NF- \u03ba b and MAPK pathways. Am J Chin Med. 2019;47:97\u2013117.","journal-title":"Am J Chin Med"},{"key":"1222_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1872214810666161020154905","volume":"10","author":"V Sidarala","year":"2017","unstructured":"Sidarala V, Kowluru A. The regulatory roles of mitogen-activated protein kinase (MAPK) pathways in health and diabetes: lessons learned from the pancreatic \u03b2-cell. Recent Pat Endocr Metab Immune Drug Discov. 2017;10:76\u201384.","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"1222_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11010-016-2878-8","volume":"426","author":"KC Nandipati","year":"2017","unstructured":"Nandipati KC, Subramanian S, Agrawal DK. Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance. Mol Cell Biochem. 2017;426:27\u201345.","journal-title":"Mol Cell Biochem"},{"key":"1222_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860\u20137.","journal-title":"Nature"},{"key":"1222_CR34","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","volume":"1863","author":"JS Bhatti","year":"2017","unstructured":"Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria based therapeutic strategies. Biochim Biophys Acta (BBA). 2017;1863:1066\u201377.","journal-title":"Biochim Biophys Acta (BBA)"},{"key":"1222_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1006376","volume":"13","author":"S Dini\u0107","year":"2022","unstructured":"Dini\u0107 S, Aramba\u0161i\u0107 Jovanovi\u0107 J, Uskokovi\u0107 A, Mihailovi\u0107 M, Grdovi\u0107 N, Toli\u0107 A, et al. Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management. Front Endocrinol (Lausanne). 2022;13:1006376.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/ars.2016.6755","volume":"26","author":"PA Gerber","year":"2017","unstructured":"Gerber PA, Rutter GA. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxid Redox Signal. 2017;26:501\u201318.","journal-title":"Antioxid Redox Signal"},{"key":"1222_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44\u201384.","journal-title":"Int J Biochem Cell Biol"},{"key":"1222_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","volume":"52","author":"JL Evans","year":"2003","unstructured":"Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes. 2003;52:1\u20138.","journal-title":"Diabetes"},{"key":"1222_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/acupmed-2015-010942","volume":"33","author":"PV Peplow","year":"2015","unstructured":"Peplow PV. Electroacupuncture treatment of insulin resistance in diabetes mellitus. Acupunct Med. 2015;33:347\u20139.","journal-title":"Acupunct Med"},{"key":"1222_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1074\/jbc.M113.533240","volume":"289","author":"J Ma","year":"2014","unstructured":"Ma J, Nakagawa Y, Kojima I, Shibata H. Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes. J Biol Chem. 2014;289:133\u201342.","journal-title":"J Biol Chem"},{"key":"1222_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1530\/JOE-16-0662","volume":"234","author":"M Hatem-Vaquero","year":"2017","unstructured":"Hatem-Vaquero M, Griera M, Garc\u00eda-Jerez A, Luengo A, \u00c1lvarez J, Rubio JA, et al. Peripheral insulin resistance in ILK-depleted mice by reduction of GLUT4 expression. J Endocrinol. 2017;234:115\u201328.","journal-title":"J Endocrinol"},{"key":"1222_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-021-02669-8","volume":"24","author":"S Li","year":"2022","unstructured":"Li S, Huang Y. Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy. Clin Transl Oncol. 2022;24:1\u201312.","journal-title":"Clin Transl Oncol"},{"key":"1222_CR43","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s10753-024-02022-5","volume":"47","author":"X Wang","year":"2024","unstructured":"Wang X, Wei T, Luo J, Lang K, Song Y, Ning X, et al. Iron overload-dependent ferroptosis aggravates LPS-induced acute lung injury by impairing mitochondrial function. Inflammation. 2024;47:2013\u201326.","journal-title":"Inflammation"},{"key":"1222_CR44","doi-asserted-by":"publisher","first-page":"9999612","DOI":"10.1155\/2021\/9999612","volume":"2021","author":"W Sha","year":"2021","unstructured":"Sha W, Hu F, Xi Y, Chu Y, Bu S. Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res. 2021;2021:9999612.","journal-title":"J Diabetes Res"},{"key":"1222_CR45","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82:2215\u201327.","journal-title":"Mol Cell"},{"key":"1222_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26:165\u201376.","journal-title":"Trends Cell Biol"},{"key":"1222_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"1222_CR48","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, Winter GE, Musavi LS, Lee ED, Snijder B, Rebsamen M, et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol. 2015;10:1604\u20139.","journal-title":"ACS Chem Biol"},{"key":"1222_CR49","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","volume":"136","author":"K Ding","year":"2023","unstructured":"Ding K, Liu C, Li L, Yang M, Jiang N, Luo S, et al. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chin Med J (Engl). 2023;136:2521\u201337.","journal-title":"Chin Med J (Engl)"},{"key":"1222_CR50","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/biomedicines8080274","volume":"8","author":"L Gil-de-G\u00f3mez","year":"2020","unstructured":"Gil-de-G\u00f3mez L, Monge P, Rodr\u00edguez JP, Astudillo AM, Balboa MA, Balsinde J. Phospholipid arachidonic acid remodeling during phagocytosis in mouse peritoneal macrophages. Biomedicines. 2020;8:274.","journal-title":"Biomedicines"},{"key":"1222_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.toxlet.2023.08.001","volume":"384","author":"N Rahimi Kakavandi","year":"2023","unstructured":"Rahimi Kakavandi N, Mousavi T, Asadi T, Moradi A, Esmaeili M, Habibian Sezavar A, et al. An updated systematic review and dose-response meta-analysis on the relation between exposure to arsenic and risk of type 2 diabetes. Toxicol Lett. 2023;384:115\u201327.","journal-title":"Toxicol Lett"},{"key":"1222_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.taap.2007.08.019","volume":"225","author":"A D\u00edaz-Villase\u00f1or","year":"2007","unstructured":"D\u00edaz-Villase\u00f1or A, Burns AL, Hiriart M, Cebri\u00e1n ME, Ostrosky-Wegman P. Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol Appl Pharmacol. 2007;225:123\u201333.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1222_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk1200","volume":"10","author":"Q Huang","year":"2024","unstructured":"Huang Q, Ru Y, Luo Y, Luo X, Liu D, Ma Y, et al. Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases. Sci Adv. 2024;10:eadk1200.","journal-title":"Sci Adv"},{"key":"1222_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2019.121390","volume":"384","author":"S Wei","year":"2020","unstructured":"Wei S, Qiu T, Yao X, Wang N, Jiang L, Jia X, et al. Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway. J Hazard Mater. 2020;384:121390.","journal-title":"J Hazard Mater"},{"key":"1222_CR55","volume":"5","author":"D Basuli","year":"2014","unstructured":"Basuli D, Stevens RG, Torti FM, Torti SV. Epidemiological associations between iron and cardiovascular disease and diabetes. Front Pharmacol. 2014;5:117.","journal-title":"Front Pharmacol"},{"key":"1222_CR56","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2337\/db10-0593","volume":"60","author":"J Huang","year":"2011","unstructured":"Huang J, Jones D, Luo B, Sanderson M, Soto J, Abel ED, et al. Iron overload and diabetes risk: a shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes. 2011;60:80\u20137.","journal-title":"Diabetes"},{"key":"1222_CR57","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1210\/en.2004-0392","volume":"145","author":"RC Cooksey","year":"2004","unstructured":"Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, et al. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology. 2004;145:5305\u201312.","journal-title":"Endocrinology"},{"key":"1222_CR58","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.2337\/diacare.27.10.2422","volume":"27","author":"M Jehn","year":"2004","unstructured":"Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care. 2004;27:2422\u20138.","journal-title":"Diabetes Care"},{"key":"1222_CR59","doi-asserted-by":"publisher","first-page":"11355","DOI":"10.1021\/acsnano.8b06201","volume":"12","author":"Z Shen","year":"2018","unstructured":"Shen Z, Liu T, Li Y, Lau J, Yang Z, Fan W, et al. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors. ACS Nano. 2018;12:11355\u201365.","journal-title":"ACS Nano"},{"key":"1222_CR60","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/jdi.13216","volume":"11","author":"J Liu","year":"2020","unstructured":"Liu J, Li Q, Yang Y, Ma L. Iron metabolism and type 2 diabetes mellitus: a meta-analysis and systematic review. J Diabetes Investig. 2020;11:946\u201355.","journal-title":"J Diabetes Investig"},{"key":"1222_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-022-00852-7","volume":"14","author":"S Zhang","year":"2022","unstructured":"Zhang S, Liu X, Wang J, Yuan F, Liu Y. Targeting ferroptosis with miR-144-3p to attenuate pancreatic \u03b2 cells dysfunction via regulating USP22\/SIRT1 in type 2 diabetes. Diabetol Metab Syndr. 2022;14:89.","journal-title":"Diabetol Metab Syndr"},{"key":"1222_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.it.2017.01.003","volume":"38","author":"RA Aglietti","year":"2017","unstructured":"Aglietti RA, Dueber EC. Recent insights into the molecular mechanisms underlying pyroptosis and gasdermin family functions. Trends Immunol. 2017;38:261\u201371.","journal-title":"Trends Immunol"},{"key":"1222_CR63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535:111\u20136.","journal-title":"Nature"},{"key":"1222_CR64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153\u20138.","journal-title":"Nature"},{"key":"1222_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1230646","volume":"14","author":"N Li","year":"2023","unstructured":"Li N, Zhang L, Wang X, Zhou Y, Gong L. Exploring exercise-driven inhibition of pyroptosis: novel insights into treating diabetes mellitus and its complications. Front Endocrinol (Lausanne). 2023;14:1230646.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.986565","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Xiao GY, Guo T, Song YJ, Li QM. Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications. Front Endocrinol (Lausanne). 2022;13:986565.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105885","volume":"173","author":"X Chen","year":"2021","unstructured":"Chen X, Zhang D, Li Y, Wang W, Bei W, Guo J. NLRP3 inflammasome and IL-1\u03b2 pathway in type 2 diabetes and atherosclerosis: friend or foe? Pharmacol Res. 2021;173:105885.","journal-title":"Pharmacol Res"},{"key":"1222_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.630536","volume":"12","author":"H Duez","year":"2021","unstructured":"Duez H, Pourcet B. Nuclear receptors in the control of the NLRP3 inflammasome pathway. Front Endocrinol (Lausanne). 2021;12:630536.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101100","volume":"88","author":"O Paerewijck","year":"2022","unstructured":"Paerewijck O, Lamkanfi M. The human inflammasomes. Mol Aspects Med. 2022;88:101100.","journal-title":"Mol Aspects Med"},{"key":"1222_CR70","doi-asserted-by":"publisher","first-page":"1052756","DOI":"10.3389\/fimmu.2023.1052756","volume":"14","author":"S Lu","year":"2023","unstructured":"Lu S, Li Y, Qian Z, Zhao T, Feng Z, Weng X, et al. Role of the inflammasome in insulin resistance and type 2 diabetes mellitus. Front Immunol. 2023;14:1052756.","journal-title":"Front Immunol"},{"key":"1222_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120850","volume":"9","author":"S Ding","year":"2019","unstructured":"Ding S, Xu S, Ma Y, Liu G, Jang H, Fang J. Modulatory mechanisms of the NLRP3 inflammasomes in diabetes. Biomolecules. 2019;9:850.","journal-title":"Biomolecules"},{"key":"1222_CR72","first-page":"94","volume":"16","author":"F Sakhaei","year":"2020","unstructured":"Sakhaei F, Keshvari M, Asgary S, Salehizadeh L, Rastqar A, Samsam-Shariat SZ. Enzymatic antioxidant system and endothelial function in patients with metabolic syndrome. ARYA Atheroscler. 2020;16:94\u2013101.","journal-title":"ARYA Atheroscler"},{"key":"1222_CR73","doi-asserted-by":"publisher","first-page":"303","DOI":"10.7570\/jomes20090","volume":"29","author":"A Sachan","year":"2020","unstructured":"Sachan A, Singh A, Shukla S, Aggarwal S, Mir I, Yadav R. Serum adipocytokines levels and their association with insulin sensitivity in morbidly obese individuals undergoing bariatric surgery. J Obes Metab Syndr. 2020;29:303\u201312.","journal-title":"J Obes Metab Syndr"},{"key":"1222_CR74","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2174\/1573399816666201103143818","volume":"17","author":"RA Babel","year":"2021","unstructured":"Babel RA, Dandekar MP. A review on cellular and molecular mechanisms linked to the development of diabetes complications. Curr Diabet Rev. 2021;17:457\u201373.","journal-title":"Curr Diabet Rev"},{"key":"1222_CR75","doi-asserted-by":"publisher","first-page":"8905917","DOI":"10.1155\/2019\/8905917","volume":"2019","author":"H Wei","year":"2019","unstructured":"Wei H, Bu R, Yang Q, Jia J, Li T, Wang Q, et al. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway. J Diabet Res. 2019;2019:8905917.","journal-title":"J Diabet Res"},{"key":"1222_CR76","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/ars.2018.7582","volume":"30","author":"F Iannantuoni","year":"2019","unstructured":"Iannantuoni F, Diaz-Morales N, Escribano-Lopez I, Sola E, Roldan-Torres I, Apostolova N, et al. Does glycemic control modulate the impairment of NLRP3 inflammasome activation in type 2 diabetes? Antioxid Redox Signal. 2019;30:232\u201340.","journal-title":"Antioxid Redox Signal"},{"key":"1222_CR77","doi-asserted-by":"publisher","DOI":"10.1177\/2058738418788749","volume":"32","author":"S Morikawa","year":"2018","unstructured":"Morikawa S, Kaneko N, Okumura C, Taguchi H, Kurata M, Yamamoto T, et al. IAPP\/amylin deposition, which is correlated with expressions of ASC and IL-1\u03b2 in \u03b2-cells of Langerhans\u2019 islets, directly initiates NLRP3 inflammasome activation. Int J Immunopathol Pharmacol. 2018;32:2058738418788749.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1222_CR78","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cr.2013.168","volume":"24","author":"Y Feng","year":"2014","unstructured":"Feng Y, He D, Yao Z, Klionsky DJ. The machinery of macroautophagy. Cell Res. 2014;24:24\u201341.","journal-title":"Cell Res"},{"key":"1222_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221:3\u201312.","journal-title":"J Pathol"},{"key":"1222_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166666","volume":"1869","author":"A Sehrawat","year":"2023","unstructured":"Sehrawat A, Mishra J, Mastana SS, Navik U, Bhatti GK, Reddy PH, et al. Dysregulated autophagy: a key player in the pathophysiology of type 2 diabetes and its complications. Biochimica et Biophysica Acta (BBA). 2023;1869:166666.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"1222_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21176275.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1222_CR82","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s12276-021-00625-8","volume":"54","author":"SG Bouret","year":"2022","unstructured":"Bouret SG. Developmental programming of hypothalamic melanocortin circuits. Exp Mol Med. 2022;54(4):403\u201313.","journal-title":"Exp Mol Med"},{"key":"1222_CR83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev-physiol-022516-034110","volume":"79","author":"C Toda","year":"2017","unstructured":"Toda C, Santoro A, Kim JD, Diano S. POMC neurons: from birth to death. Annu Rev Physiol. 2017;79:209\u201336.","journal-title":"Annu Rev Physiol"},{"key":"1222_CR84","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cmet.2011.12.016","volume":"15","author":"B Coup\u00e9","year":"2012","unstructured":"Coup\u00e9 B, Ishii Y, Dietrich MO, Komatsu M, Horvath TL, Bouret SG. Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregulation. Cell Metab. 2012;15:247\u201355.","journal-title":"Cell Metab"},{"key":"1222_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101084","volume":"42","author":"F Yuan","year":"2020","unstructured":"Yuan F, Yin H, Deng Y, Jiao F, Jiang H, Niu Y, et al. Overexpression of Smad7 in hypothalamic POMC neurons disrupts glucose balance by attenuating central insulin signaling. Mol Metab. 2020;42:101084.","journal-title":"Mol Metab"},{"key":"1222_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040831","author":"PP Devarshi","year":"2017","unstructured":"Devarshi PP, McNabney SM, Henagan TM. Skeletal muscle nucleo-mitochondrial crosstalk in obesity and type 2 diabetes. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18040831.","journal-title":"Int J Mol Sci"},{"key":"1222_CR87","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1113\/JP274337","volume":"595","author":"JC Drake","year":"2017","unstructured":"Drake JC, Yan Z. Mitophagy in maintaining skeletal muscle mitochondrial proteostasis and metabolic health with ageing. J Physiol. 2017;595:6391\u20139.","journal-title":"J Physiol"},{"key":"1222_CR88","doi-asserted-by":"publisher","first-page":"43775","DOI":"10.1038\/srep43775","volume":"7","author":"AB M\u00f8ller","year":"2017","unstructured":"M\u00f8ller AB, Kampmann U, Hedegaard J, Thorsen K, Nordentoft I, Vendelbo MH, et al. Altered gene expression and repressed markers of autophagy in skeletal muscle of insulin resistant patients with type 2 diabetes. Sci Rep. 2017;7:43775.","journal-title":"Sci Rep"},{"key":"1222_CR89","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jfda.2018.01.006","volume":"26","author":"YC Chang","year":"2018","unstructured":"Chang YC, Liu HW, Chen YT, Chen YA, Chen YJ, Chang SJ. Resveratrol protects muscle cells against palmitate-induced cellular senescence and insulin resistance through ameliorating autophagic flux. J Food Drug Anal. 2018;26:1066\u201374.","journal-title":"J Food Drug Anal"},{"key":"1222_CR90","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.stem.2022.07.009","volume":"29","author":"X Hong","year":"2022","unstructured":"Hong X, Isern J, Campanario S, Perdiguero E, Ram\u00edrez-Pardo I, Segal\u00e9s J, et al. Mitochondrial dynamics maintain muscle stem cell regenerative competence throughout adult life by regulating metabolism and mitophagy. Cell Stem Cell. 2022;29:1298-314.e10.","journal-title":"Cell Stem Cell"},{"key":"1222_CR91","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/cddiscovery.2016.61","volume":"2","author":"T Lam","year":"2016","unstructured":"Lam T, Harmancey R, Vasquez H, Gilbert B, Patel N, Hariharan V, et al. Reversal of intramyocellular lipid accumulation by lipophagy and a p62-mediated pathway. Cell Death Discov. 2016;2:16061.","journal-title":"Cell Death Discov"},{"key":"1222_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101138","volume":"44","author":"SO Jensen-Cody","year":"2021","unstructured":"Jensen-Cody SO, Potthoff MJ. Hepatokines and metabolism: deciphering communication from the liver. Mol Metab. 2021;44:101138.","journal-title":"Mol Metab"},{"key":"1222_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3762","volume":"40","author":"X Yang","year":"2024","unstructured":"Yang X, Ding W, Chen Z, Lai K, Liu Y. The role of autophagy in insulin resistance and glucolipid metabolism and potential use of autophagy modulating natural products in the treatment of type 2 diabetes mellitus. Diabetes Metab Res Rev. 2024;40:e3762.","journal-title":"Diabetes Metab Res Rev"},{"key":"1222_CR94","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nm.4481","volume":"24","author":"A Bartelt","year":"2018","unstructured":"Bartelt A, Widenmaier SB, Schlein C, Johann K, Goncalves RLS, Eguchi K, et al. Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity. Nat Med. 2018;24:292\u2013303.","journal-title":"Nat Med"},{"key":"1222_CR95","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2337\/db11-1652","volume":"62","author":"T Otoda","year":"2013","unstructured":"Otoda T, Takamura T, Misu H, Ota T, Murata S, Hayashi H, et al. Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver. Diabetes. 2013;62:811\u201324.","journal-title":"Diabetes"},{"key":"1222_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0670-x","volume":"15","author":"A Kohlgruber","year":"2015","unstructured":"Kohlgruber A, Lynch L. Adipose tissue inflammation in the pathogenesis of type 2 diabetes. Curr Diab Rep. 2015;15:92.","journal-title":"Curr Diab Rep"},{"key":"1222_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.373","volume":"8","author":"\u00c1F Fern\u00e1ndez","year":"2017","unstructured":"Fern\u00e1ndez \u00c1F, B\u00e1rcena C, Mart\u00ednez-Garc\u00eda GG, Tamargo-G\u00f3mez I, Su\u00e1rez MF, Pietrocola F, et al. Autophagy couteracts weight gain, lipotoxicity and pancreatic \u03b2-cell death upon hypercaloric pro-diabetic regimens. Cell Death Dis. 2017;8:e2970.","journal-title":"Cell Death Dis"},{"key":"1222_CR98","first-page":"892","volume":"9","author":"Z Abad-Jim\u00e9nez","year":"2020","unstructured":"Abad-Jim\u00e9nez Z, L\u00f3pez-Dom\u00e8nech S, D\u00edaz-R\u00faa R, Iannantuoni F, G\u00f3mez-Abril S, Peria\u00f1ez-G\u00f3mez D, et al. Systemic Oxidative Stress and Visceral Adipose Tissue Mediators of NLRP3 Inflammasome and Autophagy Are Reduced in Obese Type 2 Diabetic Patients Treated with Metformin. Antioxidants (Basel, Switzerland). 2020;9:892.","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"1222_CR99","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1210\/en.2012-1625","volume":"153","author":"HJ Jansen","year":"2012","unstructured":"Jansen HJ, van Essen P, Koenen T, Joosten LA, Netea MG, Tack CJ, et al. Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. Endocrinology. 2012;153:5866\u201374.","journal-title":"Endocrinology"},{"key":"1222_CR100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mce.2015.03.015","volume":"409","author":"J Kosacka","year":"2015","unstructured":"Kosacka J, Kern M, Kl\u00f6ting N, Paeschke S, Rudich A, Haim Y, et al. Autophagy in adipose tissue of patients with obesity and type 2 diabetes. Mol Cell Endocrinol. 2015;409:21\u201332.","journal-title":"Mol Cell Endocrinol"},{"key":"1222_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17985-w","volume":"11","author":"T Yamamuro","year":"2020","unstructured":"Yamamuro T, Kawabata T, Fukuhara A, Saita S, Nakamura S, Takeshita H, et al. Age-dependent loss of adipose Rubicon promotes metabolic disorders via excess autophagy. Nat Commun. 2020;11:4150.","journal-title":"Nat Commun"},{"key":"1222_CR102","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cmet.2008.08.013","volume":"8","author":"HS Jung","year":"2008","unstructured":"Jung HS, Chung KW, Won Kim J, Kim J, Komatsu M, Tanaka K, et al. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab. 2008;8:318\u201324.","journal-title":"Cell Metab"},{"key":"1222_CR103","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00125-009-1347-2","volume":"52","author":"M Masini","year":"2009","unstructured":"Masini M, Bugliani M, Lupi R, del Guerra S, Boggi U, Filipponi F, et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia. 2009;52:1083\u20136.","journal-title":"Diabetologia"},{"key":"1222_CR104","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.2337\/db16-1009","volume":"66","author":"FP Zummo","year":"2017","unstructured":"Zummo FP, Cullen KS, Honkanen-Scott M, Shaw JAM, Lovat PE, Arden C. Glucagon-like peptide 1 protects pancreatic \u03b2-cells from death by increasing autophagic flux and restoring lysosomal function. Diabetes. 2017;66:1272\u201385.","journal-title":"Diabetes"},{"key":"1222_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1151723","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, Liu Y, Li X. Effects of intestinal flora on polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1151723.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1208044","volume":"14","author":"AH Asseri","year":"2023","unstructured":"Asseri AH, Bakhsh T, Abuzahrah SS, Ali S, Rather IA. The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice. Front Pharmacol. 2023;14:1208044.","journal-title":"Front Pharmacol"},{"key":"1222_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109138","volume":"117","author":"Q Ma","year":"2019","unstructured":"Ma Q, Li Y, Li P, Wang M, Wang J, Tang Z, et al. Research progress in the relationship between type 2 diabetes mellitus and intestinal flora. Biomed Pharmacother. 2019;117:109138.","journal-title":"Biomed Pharmacother"},{"key":"1222_CR108","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/hmg\/ddad084","volume":"32","author":"AK Giri","year":"2023","unstructured":"Giri AK, Prasad G, Parekatt V, Rajashekar D, Tandon N, Bharadwaj D. Epigenome-wide methylation study identified two novel CpGs associated with T2DM risk and a network of co-methylated CpGs capable of patient\u2019s classifications. Hum Mol Genet. 2023;32:2576\u201386.","journal-title":"Hum Mol Genet"},{"key":"1222_CR109","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-022-00890-w","volume":"20","author":"JY Wang","year":"2022","unstructured":"Wang JY, Ma D, Luo M, Tan YP, Ou Z, Tian G, et al. Effect of spermidine on ameliorating spermatogenic disorders in diabetic mice via regulating glycolysis pathway. Reprod Biol Endocrinol. 2022;20:45.","journal-title":"Reprod Biol Endocrinol"},{"key":"1222_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101927","volume":"83","author":"J Li","year":"2024","unstructured":"Li J, Huang Y, Yang X, Cai Y, Wang Y, Dai W, et al. Tyrosine-phosphorylated DNER sensitizes insulin signaling in hepatic gluconeogenesis by inducing proteasomal degradation of TRB3. Mol Metab. 2024;83:101927.","journal-title":"Mol Metab"},{"key":"1222_CR111","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189\u2013200.","journal-title":"Gut Microbes"},{"key":"1222_CR112","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4291\/wjgp.v6.i4.110","volume":"6","author":"CK Chakraborti","year":"2015","unstructured":"Chakraborti CK. New-found link between microbiota and obesity. World J Gastrointest Pathophysiol. 2015;6:110\u20139.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1222_CR113","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00592-023-02088-x","volume":"60","author":"S Longo","year":"2023","unstructured":"Longo S, Rizza S, Federici M. Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes. Acta Diabetol. 2023;60:1007\u201317.","journal-title":"Acta Diabetol"},{"key":"1222_CR114","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tips.2013.02.002","volume":"34","author":"LB Bindels","year":"2013","unstructured":"Bindels LB, Dewulf EM, Delzenne NM. GPR43\/FFA2: physiopathological relevance and therapeutic prospects. Trends Pharmacol Sci. 2013;34:226\u201332.","journal-title":"Trends Pharmacol Sci"},{"key":"1222_CR115","doi-asserted-by":"publisher","first-page":"E253","DOI":"10.1152\/ajpendo.00331.2016","volume":"312","author":"TY Huang","year":"2017","unstructured":"Huang TY, Zheng D, Houmard JA, Brault JJ, Hickner RC, Cortright RN. Overexpression of PGC-1\u03b1 increases peroxisomal activity and mitochondrial fatty acid oxidation in human primary myotubes. Am J Physiol Endocrinol Metab. 2017;312:E253\u201363.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1222_CR116","first-page":"4305","volume":"11","author":"MAG Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez MAG, Canfora EE, Jocken JWE, Blaak EE. The short-chain fatty acid acetate in body weight control and insulin sensitivity. Nutrients. 2019;11:4305.","journal-title":"Nutrients"},{"key":"1222_CR117","doi-asserted-by":"publisher","first-page":"1468s","DOI":"10.3945\/jn.116.240754","volume":"147","author":"L Wen","year":"2017","unstructured":"Wen L, Duffy A. Factors influencing the gut microbiota, inflammation, and type 2 diabetes. J Nutr. 2017;147:1468s-s1475.","journal-title":"J Nutr"},{"key":"1222_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02546-x","volume":"7","author":"EE Canfora","year":"2017","unstructured":"Canfora EE, van der Beek CM, Jocken JWE, Goossens GH, Holst JJ, Olde Damink SWM, et al. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight\/obese men: a randomized crossover trial. Sci Rep. 2017;7:2360.","journal-title":"Sci Rep"},{"key":"1222_CR119","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13098-023-01207-6","volume":"15","author":"Y Hou","year":"2023","unstructured":"Hou Y, Zhai X, Wang X, Wu Y, Wang H, Qin Y, et al. Research progress on the relationship between bile acid metabolism and type 2 diabetes mellitus. Diabetol Metab Syndr. 2023;15:235.","journal-title":"Diabetol Metab Syndr"},{"key":"1222_CR120","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15:111\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1222_CR121","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1055\/a-1069-7330","volume":"128","author":"GE Delgado","year":"2020","unstructured":"Delgado GE, Kr\u00e4mer BK, Scharnagl H, Fauler G, Stojakovic T, M\u00e4rz W, et al. Bile acids in patients with uncontrolled type 2 diabetes mellitus - the effect of two days of oatmeal treatment. Exp Clin Endocrinol Diabetes. 2020;128:624\u201330.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1222_CR122","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/hep.27616","volume":"61","author":"JY Chiang","year":"2015","unstructured":"Chiang JY. Sphingosine-1-phosphate receptor 2: a novel bile acid receptor and regulator of hepatic lipid metabolism? Hepatology. 2015;61:1118\u201320.","journal-title":"Hepatology"},{"key":"1222_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154733","volume":"113","author":"D Tawulie","year":"2023","unstructured":"Tawulie D, Jin L, Shang X, Li Y, Sun L, Xie H, et al. Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism. Phytomedicine. 2023;113:154733.","journal-title":"Phytomedicine"},{"key":"1222_CR124","doi-asserted-by":"publisher","first-page":"26913","DOI":"10.1074\/jbc.M111.248203","volume":"286","author":"M Watanabe","year":"2011","unstructured":"Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E, et al. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem. 2011;286:26913\u201320.","journal-title":"J Biol Chem"},{"key":"1222_CR125","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.3390\/ijms25084305","volume":"25","author":"K Wang","year":"2024","unstructured":"Wang K, Lai W, Min T, Wei J, Bai Y, Cao H, et al. The effect of enteric-derived lipopolysaccharides on obesity. Int J Mol Sci. 2024;25:4305.","journal-title":"Int J Mol Sci"},{"key":"1222_CR126","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.4049\/jimmunol.170.10.5165","volume":"170","author":"TK Means","year":"2003","unstructured":"Means TK, Hayashi F, Smith KD, Aderem A, Luster AD. The toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol. 2003;170:5165\u201375.","journal-title":"J Immunol"},{"key":"1222_CR127","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12902-025-01861-z","volume":"25","author":"L Qin","year":"2025","unstructured":"Qin L, Liu R, Jia Z, Xu W, Wang L, Tian H, et al. Multiple low-dose radiation ameliorates type-2 diabetes mellitus via gut microbiota modulation to activate TLR4\/MyD88\/NF-\u03baB pathway. BMC Endocr Disord. 2025;25:32.","journal-title":"BMC Endocr Disord"},{"key":"1222_CR128","doi-asserted-by":"publisher","first-page":"eaat4271","DOI":"10.1126\/scitranslmed.aat4271","volume":"10","author":"M Bodogai","year":"2018","unstructured":"Bodogai M, O\u2019Connell J, Kim K, Kim Y, Moritoh K, Chen C, et al. Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells. Sci Transl Med. 2018;10:eaat4271.","journal-title":"Sci Transl Med"},{"key":"1222_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101261","volume":"52","author":"PJ White","year":"2021","unstructured":"White PJ, McGarrah RW, Herman MA, Bain JR, Shah SH, Newgard CB. Insulin action, type 2 diabetes, and branched-chain amino acids: a two-way street. Mol Metab. 2021;52:101261.","journal-title":"Mol Metab"},{"key":"1222_CR130","first-page":"733","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Fang Y, Vrablik M. Homeostasis model assessment for insulin resistance mediates the positive association of triglycerides with diabetes. Diagnostics (Basel, Switzerland). 2024;14:733.","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"1222_CR131","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3390\/nu12123719","volume":"12","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Neculae E, Costea CF, Ciocoiu M, Hurjui LL, et al. Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM). Nutrients. 2020;12:3719.","journal-title":"Nutrients"},{"key":"1222_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.93","volume":"48","author":"MS Yoon","year":"2016","unstructured":"Yoon MS, Choi CS. The role of amino acid-induced mammalian target of rapamycin complex 1(mTORC1) signaling in insulin resistance. Exp Mol Med. 2016;48:e201.","journal-title":"Exp Mol Med"},{"key":"1222_CR133","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311\u201326.","journal-title":"Cell Metab"},{"key":"1222_CR134","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/nu13051389","volume":"13","author":"S Croci","year":"2021","unstructured":"Croci S, D\u2019Apolito LI, Gasperi V, Catani MV, Savini I. Dietary strategies for management of metabolic syndrome: role of gut microbiota metabolites. Nutrients. 2021;13:1389.","journal-title":"Nutrients"},{"key":"1222_CR135","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2147\/DMSO.S511068","volume":"18","author":"Y Wu","year":"2025","unstructured":"Wu Y, Li T, Chen B, Sun Y, Song L, Wang Y, et al. Tryptophan indole derivatives: key players in type 2 diabetes mellitus. Diabet Metab Syndr Obes. 2025;18:1563\u201374.","journal-title":"Diabet Metab Syndr Obes"},{"key":"1222_CR136","first-page":"2528","volume":"10","author":"R Ballan","year":"2021","unstructured":"Ballan R, Saad SMI. Characteristics of the gut microbiota and potential effects of probiotic supplements in individuals with type 2 diabetes mellitus. Foods (Basel, Switzerland). 2021;10:2528.","journal-title":"Foods (Basel, Switzerland)"},{"key":"1222_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104578","volume":"26","author":"Y Chen","year":"2025","unstructured":"Chen Y, Wen Q, Yang B, Feng L, Jia X. Active constituent of HQS in T2DM intervention: efficacy and mechanistic insights. Int J Mol Sci. 2025;26:4578.","journal-title":"Int J Mol Sci"},{"key":"1222_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.728032","volume":"12","author":"Z Dou","year":"2021","unstructured":"Dou Z, Xia Y, Zhang J, Li Y, Zhang Y, Zhao L, et al. Syndrome differentiation and treatment regularity in traditional Chinese medicine for type 2 diabetes: a text mining analysis. Front Endocrinol (Lausanne). 2021;12:728032.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1222_CR139","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1080\/13880209.2023.2248188","volume":"61","author":"J Yu","year":"2023","unstructured":"Yu J, Wang S, Yang J, Huang W, Tang B, Peng W, et al. Exploring the mechanisms of action of Zengye decoction (ZYD) against Sjogren\u2019s syndrome (SS) using network pharmacology and animal experiment. Pharm Biol. 2023;61(1):1286\u201397.","journal-title":"Pharm Biol"},{"key":"1222_CR140","doi-asserted-by":"publisher","first-page":"1588786","DOI":"10.1155\/2022\/1588786","volume":"2022","author":"XY Dai","year":"2022","unstructured":"Dai XY, Hu Q, Yao JQ, Wu XJ, Miao YF, Li J, et al. Zengye decoction attenuated severe acute pancreatitis complicated with acute kidney injury by modulating the gut microbiome and serum amino acid metabolome. Evid Based Complement Alternat Med. 2022;2022:1588786.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1222_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.668418","volume":"12","author":"JZ Lu","year":"2021","unstructured":"Lu JZ, Ye D, Ma BL. Constituents, pharmacokinetics, and pharmacology of gegen-qinlian decoction. Front Pharmacol. 2021;12:668418.","journal-title":"Front Pharmacol"},{"key":"1222_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114786","volume":"285","author":"L He","year":"2022","unstructured":"He L, Bao T, Yang Y, Wang H, Gu C, Chen J, et al. Exploring the pathogenesis of type 2 diabetes mellitus intestinal damp-heat syndrome and the therapeutic effect of Gegen Qinlian decoction from the perspective of exosomal miRNA. J Ethnopharmacol. 2022;285:114786.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR143","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024210","volume":"100","author":"Y Ren","year":"2021","unstructured":"Ren Y, Xiong P, Zhong C, Zhang P, Jia B. The effect of Gegen Qinlian decoction on clinical prognosis and islet function for type 2 diabetic mellitus: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100:e24210.","journal-title":"Medicine (Baltimore)"},{"key":"1222_CR144","doi-asserted-by":"publisher","first-page":"9922292","DOI":"10.1155\/2021\/9922292","volume":"2021","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Song N, Wang SQ, Wang Y, Zhao YK, Zhu XD. effect of Gegen Qinlian decoction on hepatic gluconeogenesis in ZDF Rats with Type 2 diabetes mellitus based on the Farnesol X receptor\/ceramide signaling pathway regulating mitochondrial metabolism and endoplasmic reticulum stress. Evid Based Complement Alternat Med. 2021;2021:9922292.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1222_CR145","doi-asserted-by":"publisher","first-page":"1316269","DOI":"10.3389\/fendo.2023.1316269","volume":"14","author":"Y Tan","year":"2023","unstructured":"Tan Y, Liu S, Huang M, Cheng H, Xu B, Luo H, et al. Efficacy and safety of Gegen Qinlian decoction in the treatment of type II diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Front Endocrinol (Lausanne). 2023;14:1316269.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115196","volume":"292","author":"R Tian","year":"2022","unstructured":"Tian R, Liu X, Jing L, Yang L, Xie N, Hou Y, et al. Huang-Lian-Jie-Du decoction attenuates cognitive dysfunction of rats with type 2 diabetes by regulating autophagy and NLRP3 inflammasome activation. J Ethnopharmacol. 2022;292:115196.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2023.109698","volume":"272","author":"Z Hu","year":"2023","unstructured":"Hu Z, Meng G, Zhang L, Zhang M, Cui H, Tang H. Protective effect of Huanglianjiedu decoction on microcystin-LR induced nerve injury. Comp Biochem Physiol C Toxicol Pharmacol. 2023;272:109698.","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"1222_CR148","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.phymed.2013.11.004","volume":"21","author":"XJ Zhang","year":"2014","unstructured":"Zhang XJ, Deng YX, Shi QZ, He MY, Chen B, Qiu XM. Hypolipidemic effect of the Chinese polyherbal Huanglian Jiedu decoction in type 2 diabetic rats and its possible mechanism. Phytomedicine. 2014;21:615\u201323.","journal-title":"Phytomedicine"},{"key":"1222_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114784","volume":"284","author":"T He","year":"2022","unstructured":"He T, Wang M, Kong J, Wang Q, Tian Y, Li C, et al. Integrating network pharmacology and non-targeted metabolomics to explore the common mechanism of Coptis Categorized Formula improving T2DM zebrafish. J Ethnopharmacol. 2022;284:114784.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR150","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.curtheres.2012.09.002","volume":"73","author":"Q Yi","year":"2012","unstructured":"Yi Q, He XE, Luo KF, Zhang GS, Liu YH, Xue Q, et al. Protection of long-term treatment with huang-lian-jie-du-tang on vascular endothelium in rats with type 2 diabetes mellitus. Curr Ther Res Clin Exp. 2012;73:174\u201385.","journal-title":"Curr Ther Res Clin Exp"},{"key":"1222_CR151","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3389\/fmicb.2018.02380","volume":"9","author":"M Chen","year":"2018","unstructured":"Chen M, Liao Z, Lu B, Wang M, Lin L, Zhang S, et al. Huang-Lian-Jie-Du-decoction ameliorates hyperglycemia and insulin resistant in association with gut microbiota modulation. Front Microbiol. 2018;9:2380.","journal-title":"Front Microbiol"},{"key":"1222_CR152","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000536453","volume":"31","author":"M Wang","year":"2024","unstructured":"Wang M, Wang T, Gu F. Efficacy of Huanglian Jiedu decoction for type 2 diabetes mellitus: a systematic review and meta-analysis. Complement Med Res. 2024;31:187\u2013200.","journal-title":"Complement Med Res"},{"key":"1222_CR153","first-page":"1306","volume":"44","author":"W Zhang","year":"2024","unstructured":"Zhang W, Gu H, Chen P, Wu S, Ma H, Yao L. Compound Yuye Decoction protects diabetic rats against cardiomyopathy by inhibiting myocardial apoptosis and inflammation via regulating the PI3K\/Akt signaling pathway. Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:1306\u201314.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1222_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116222","volume":"308","author":"F Guo","year":"2023","unstructured":"Guo F, Yao L, Zhang W, Chen P, Hao R, Huang X, et al. The therapeutic mechanism of Yuye decoction on type 2 diabetes mellitus based on network pharmacology and experimental verification. J Ethnopharmacol. 2023;308:116222.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR155","doi-asserted-by":"publisher","first-page":"1159707","DOI":"10.3389\/fendo.2023.1159707","volume":"14","author":"Z Ma","year":"2023","unstructured":"Ma Z, Sun W, Wang L, Wang Y, Pan B, Su X, et al. Integrated 16S rRNA sequencing and nontargeted metabolomics analysis to reveal the mechanisms of Yu-Ye Tang on type 2 diabetes mellitus rats. Front Endocrinol (Lausanne). 2023;14:1159707.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119158","volume":"340","author":"X Wang","year":"2025","unstructured":"Wang X, Zhong ZJ, Chen PF, Deng CF, Chen XM, Xin GZ, et al. Integrating metabolomics and network pharmacology to investigate Da-Chai-Hu Decoction prevents kidney injury in diabetic mice. J Ethnopharmacol. 2025;340:119158.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116539","volume":"312","author":"S Bi","year":"2023","unstructured":"Bi S, Liu Y, Lv T, Ren Y, Liu K, Liu C, et al. Preliminary exploration of method for screening efficacy markers compatibility in TCM prescriptions based on Q-markers: Anti-inflammatory activity of Dachaihu decoction as an example. J Ethnopharmacol. 2023;312:116539.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR158","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/nu12102907","volume":"12","author":"GR Gandhi","year":"2020","unstructured":"Gandhi GR, Vasconcelos ABS, Wu DT, Li HB, Antony PJ, Li H, et al. Citrus flavonoids as promising phytochemicals targeting diabetes and related complications: a systematic review of in vitro and in vivo studies. Nutrients. 2020;12:2907.","journal-title":"Nutrients"},{"key":"1222_CR159","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.2147\/DDDT.S319260","volume":"15","author":"L Ma","year":"2021","unstructured":"Ma L, Wu F, Shao Q, Chen G, Xu L, Lu F. Baicalin alleviates oxidative stress and inflammation in diabetic nephropathy via Nrf2 and MAPK signaling pathway. Drug Des, Dev Ther. 2021;15:3207\u201321.","journal-title":"Drug Des, Dev Ther"},{"key":"1222_CR160","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4155\/ppa-2021-0027","volume":"11","author":"S Gupta","year":"2022","unstructured":"Gupta S, Buttar HS, Kaur G, Tuli HS. Baicalein: promising therapeutic applications with special reference to published patents. Pharm Pat Anal. 2022;11:23\u201332.","journal-title":"Pharm Pat Anal"},{"key":"1222_CR161","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.4314\/tjpr.v20i8.17","volume":"20","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Wang Z, Xu H, Qin L, An R, Zhang Y. Effect of Dachaihu decoction on traditional Chinese medicine-related indices of Type 2 diabetes in rats, and elucidation of its mechanism of action. Trop J Pharm Res. 2022;20:1669\u201374.","journal-title":"Trop J Pharm Res"},{"key":"1222_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.918681","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Leng Y, Fu X, Yang C, Xie H, Yuan H, et al. The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol. 2022;13:918681.","journal-title":"Front Pharmacol"},{"key":"1222_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155659","volume":"130","author":"T Fang","year":"2024","unstructured":"Fang T, Wang J, Sun S, Deng X, Xue M, Han F, et al. JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53. Phytomedicine. 2024;130:155659.","journal-title":"Phytomedicine"},{"key":"1222_CR164","doi-asserted-by":"publisher","first-page":"4483009","DOI":"10.1155\/2022\/4483009","volume":"2022","author":"HR Zhou","year":"2022","unstructured":"Zhou HR, Wang TX, Hao YY, Hou YL, Wei C, Yao B, et al. Jinlida granules reduce obesity in db\/db mice by activating beige adipocytes. Biomed Res Int. 2022;2022:4483009.","journal-title":"Biomed Res Int"},{"key":"1222_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108781","volume":"114","author":"H Zhang","year":"2019","unstructured":"Zhang H, Hao Y, Wei C, Yao B, Liu S, Zhou H, et al. Chinese medicine Jinlida granules improve high-fat-diet induced metabolic disorders via activation of brown adipose tissue in mice. Biomed Pharmacother. 2019;114:108781.","journal-title":"Biomed Pharmacother"},{"key":"1222_CR166","doi-asserted-by":"publisher","first-page":"1142327","DOI":"10.3389\/fendo.2023.1142327","volume":"14","author":"X Kang","year":"2023","unstructured":"Kang X, Sun Y, Duan Y, Zhang Y, An X, Jin D, et al. Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial. Front Endocrinol (Lausanne). 2023;14:1142327.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR167","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/1753-0407.12877","volume":"11","author":"F Lian","year":"2019","unstructured":"Lian F, Jin D, Bao Q, Zhao Y, Tong X. Effectiveness of traditional Chinese medicine Jinlida granules as an add-on therapy for type 2 diabetes: a system review and meta-analysis of randomized controlled trials. J Diabetes. 2019;11:540\u201351.","journal-title":"J Diabetes"},{"key":"1222_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114277","volume":"278","author":"H Zhang","year":"2021","unstructured":"Zhang H, Chen R, Xu C, Zhang G, Guan Y, Feng Q, et al. An integrated approach to discriminate the quality markers of Traditional Chinese medicine preparation based on multi-dimensional characteristic network: Shenqi Jiangtang Granule as a case. J Ethnopharmacol. 2021;278:114277.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113282","volume":"264","author":"H Zhang","year":"2021","unstructured":"Zhang H, Xu C, Tian Q, Zhang Y, Zhang G, Guan Y, et al. Screening and characterization of aldose reductase inhibitors from Traditional Chinese medicine based on ultrafiltration-liquid chromatography mass spectrometry and in silico molecular docking. J Ethnopharmacol. 2021;264:113282.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR170","doi-asserted-by":"publisher","first-page":"3240618","DOI":"10.1155\/2019\/3240618","volume":"2019","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Xiao X, Zheng J, Li M, Yu M, Ping F, et al. Shenqi jiangtang granule ameliorates kidney function by inhibiting apoptosis in a diabetic rat model. Evid Based Complement Alternat Med. 2019;2019:3240618.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1222_CR171","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025092","volume":"100","author":"T Li","year":"2021","unstructured":"Li T, Li H, Wu Y, Wu Q, Zhao G, Cai Z, et al. Efficacy and safety of Shenqi Jiangtang Granules plus oral hypoglycemic agent in patients with type 2 diabetes mellitus: a protocol for systematic review and meta-analysis of 15 RCTs. Medicine. 2021;100:e25092.","journal-title":"Medicine"},{"key":"1222_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114672","volume":"282","author":"S Shi","year":"2022","unstructured":"Shi S, Sun M, Liu Y, Jiang J, Li F. Insight into Shenqi Jiangtang Granule on the improved insulin sensitivity by integrating in silico and in vivo approaches. J Ethnopharmacol. 2022;282:114672.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR173","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1248\/bpb.26.156","volume":"26","author":"MT Hsieh","year":"2003","unstructured":"Hsieh MT, Cheng SJ, Lin LW, Wang WH, Wu CR. The ameliorating effects of acute and chronic administration of LiuWei Dihuang Wang on learning performance in rodents. Biol Pharm Bull. 2003;26:156\u201361.","journal-title":"Biol Pharm Bull"},{"key":"1222_CR174","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1211\/jpp.59.9.0015","volume":"59","author":"H He","year":"2007","unstructured":"He H, Yang X, Zeng X, Shi M, Yang J, Wu L, et al. Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats. J Pharm Pharmacol. 2007;59:1297\u2013305.","journal-title":"J Pharm Pharmacol"},{"key":"1222_CR175","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1055\/s-0043-118667","volume":"126","author":"A Klisic","year":"2018","unstructured":"Klisic A, Isakovic A, Kocic G, Kavaric N, Jovanovic M, Zvrko E, et al. Relationship between oxidative stress, inflammation and dyslipidemia with fatty liver index in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabet. 2018;126:371\u20138.","journal-title":"Exp Clin Endocrinol Diabet"},{"key":"1222_CR176","first-page":"3794","volume":"40","author":"M Yan","year":"2015","unstructured":"Yan M, Wei YC, Li XF, Meng J, Wu Y, Xiao W. Optimization on alcohol precipitation techniques of Liuwei Dihuang decoction by response surface methodology. Zhongguo Zhong Yao Za Zhi. 2015;40:3794\u20139.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1222_CR177","doi-asserted-by":"publisher","first-page":"7931314","DOI":"10.1155\/2016\/7931314","volume":"2016","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Yu J, Liu J, An X. The role of Liuwei Dihuang Pills and ginkgo leaf tablets in treating diabetic complications. Evid Based Complement Alternat Med. 2016;2016:7931314.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1222_CR178","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ctim.2018.08.007","volume":"40","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, An X, Liu J, Liu S, Xu W, Yu X, et al. The improvement of oxidative stress by two proprietary herbal medicines in type 2 diabetes. Complement Ther Med. 2018;40:120\u20135.","journal-title":"Complement Ther Med"},{"key":"1222_CR179","doi-asserted-by":"publisher","first-page":"1282077","DOI":"10.3389\/fphar.2023.1282077","volume":"14","author":"Y Lei","year":"2023","unstructured":"Lei Y, Huang J, Xie Z, Wang C, Li Y, Hua Y, et al. Elucidating the pharmacodynamic mechanisms of Yuquan pill in T2DM rats through comprehensive multi-omics analyses. Front Pharmacol. 2023;14:1282077.","journal-title":"Front Pharmacol"},{"key":"1222_CR180","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027555","volume":"100","author":"L Liu","year":"2021","unstructured":"Liu L, Zhang Y, Zhu Z, Yu Z, Bao P, Nan Z. Yuquan pill enhance the effect of Western medicine in treatment diabetic nephropathy: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100:e27555.","journal-title":"Medicine (Baltimore)"},{"key":"1222_CR181","doi-asserted-by":"publisher","first-page":"2562590","DOI":"10.1155\/2021\/2562590","volume":"2021","author":"S Peng","year":"2021","unstructured":"Peng S, Xie Z, Zhang X, Xie C, Kang J, Yuan H, et al. Efficacy and safety of the chinese patent medicine Yuquan Pill on type 2 diabetes mellitus patients: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2021;2021:2562590.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1222_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2023.123713","volume":"1222","author":"H Liu","year":"2023","unstructured":"Liu H, Feng C, Yang T, Zhang Z, Wei X, Sun Y, et al. Combined metabolomics and gut microbiome to investigate the effects and mechanisms of Yuquan Pill on type 2 diabetes in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2023;1222:123713.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1222_CR183","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s13063-015-0990-9","volume":"16","author":"X Sun","year":"2015","unstructured":"Sun X, Guo L, Shang H, Ren M, Wang Y, Huo D, et al. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design. Trials. 2015;16:496.","journal-title":"Trials"},{"key":"1222_CR184","doi-asserted-by":"publisher","first-page":"1872134","DOI":"10.1155\/2019\/1872134","volume":"2019","author":"Y Cao","year":"2019","unstructured":"Cao Y, Yao G, Sheng Y, Yang L, Wang Z, Yang Z, et al. JinQi Jiangtang tablet regulates gut microbiota and improve insulin sensitivity in type 2 diabetes mice. J Diabet Res. 2019;2019:1872134.","journal-title":"J Diabet Res"},{"key":"1222_CR185","doi-asserted-by":"publisher","first-page":"41858","DOI":"10.1039\/C8RA07858K","volume":"8","author":"B Jiang","year":"2018","unstructured":"Jiang B, Qu Z, Gu Y, Li X, Wang J, Zhang J, et al. Renoprotective effect of JinQi-JiangTang tablet on high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats. RSC Adv. 2018;8:41858\u201371.","journal-title":"RSC Adv"},{"key":"1222_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.895724","volume":"13","author":"S Li","year":"2022","unstructured":"Li S, Li X, Wang H, Jia X, Mao H, Dong F, et al. The hypoglycemic effect of JinQi jiangtang tablets is partially dependent on the palmatine-induced activation of the fibroblast growth factor receptor 1 signaling pathway. Front Pharmacol. 2022;13:895724.","journal-title":"Front Pharmacol"},{"key":"1222_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155957","volume":"134","author":"Z Song","year":"2024","unstructured":"Song Z, Yan A, Li Z, Shang Y, Chen R, Yang Z, et al. Integrated metabolomic and transcriptomic analysis reveals the effects and mechanisms of Jinqi Jiangtang tablets on type 2 diabetes. Phytomedicine. 2024;134:155957.","journal-title":"Phytomedicine"},{"key":"1222_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.01.016","volume":"47","author":"H Gao","year":"2019","unstructured":"Gao H, Yang Y, Deng J, Liang J, Zhang W, Feng X. A systematic review and meta-analysis on the efficacy and safety of traditional Chinese patent medicine Jinqi Jiangtang Tablet in the treatment of type 2 diabetes. Complement Ther Med. 2019;47:102021.","journal-title":"Complement Ther Med"},{"key":"1222_CR189","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cbin.12189","volume":"48","author":"R Taheri","year":"2024","unstructured":"Taheri R, Mokhtari Y, Yousefi AM, Bashash D. The PI3K\/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets. Cell Biol Int. 2024;48:1049\u201368.","journal-title":"Cell Biol Int"},{"key":"1222_CR190","doi-asserted-by":"publisher","first-page":"1192131","DOI":"10.3389\/fnut.2023.1192131","volume":"10","author":"X Yi","year":"2023","unstructured":"Yi X, Dong M, Guo N, Tian J, Lei P, Wang S, et al. Flavonoids improve type 2 diabetes mellitus and its complications: a review. Front Nutr. 2023;10:1192131.","journal-title":"Front Nutr"},{"key":"1222_CR191","first-page":"1146","volume":"12","author":"P Ansari","year":"2022","unstructured":"Ansari P, Choudhury ST, Seidel V, Rahman AB, Aziz MA, Richi AE, et al. Therapeutic potential of quercetin in the management of type-2 diabetes mellitus. Life (Basel, Switzerland). 2022;12:1146.","journal-title":"Life (Basel, Switzerland)"},{"key":"1222_CR192","first-page":"629","volume":"24","author":"JY Wang","year":"2021","unstructured":"Wang JY, Nie YX, Dong BZ, Cai ZC, Zeng XK, Du L, et al. Quercetin protects islet \u03b2-cells from oxidation-induced apoptosis via Sirt3 in T2DM. Iran J Basic Med Sci. 2021;24:629\u201335.","journal-title":"Iran J Basic Med Sci"},{"key":"1222_CR193","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3390\/nu16121870","volume":"16","author":"M Yuan","year":"2024","unstructured":"Yuan M, Sun T, Zhang Y, Guo C, Wang F, Yao Z, et al. Quercetin alleviates insulin resistance and repairs intestinal barrier in db\/db mice by modulating gut microbiota. Nutrients. 2024;16:1870.","journal-title":"Nutrients"},{"key":"1222_CR194","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1002\/fsn3.3609","volume":"11","author":"W Zhou","year":"2023","unstructured":"Zhou W, He H, Wei Q, Che L, Zhao X, Liu W, et al. Puerarin protects against acetaminophen-induced oxidative damage in liver through activation of the Keap1\/Nrf2 signaling pathway. Food Sci Nutr. 2023;11:6604\u201315.","journal-title":"Food Sci Nutr"},{"key":"1222_CR195","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1039\/D1FO04170C","volume":"13","author":"SS Zhang","year":"2022","unstructured":"Zhang SS, Zhang NN, Guo S, Liu SJ, Hou YF, Li S, et al. Glycosides and flavonoids from the extract of Pueraria thomsonii Benth leaf alleviate type 2 diabetes in high-fat diet plus streptozotocin-induced mice by modulating the gut microbiota. Food Funct. 2022;13:3931\u201345.","journal-title":"Food Funct"},{"key":"1222_CR196","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1039\/D0FO02761H","volume":"12","author":"DX Xu","year":"2021","unstructured":"Xu DX, Guo XX, Zeng Z, Wang Y, Qiu J. Puerarin improves hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathway. Food Funct. 2021;12:2726\u201340.","journal-title":"Food Funct"},{"key":"1222_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111325","volume":"137","author":"Y Liu","year":"2021","unstructured":"Liu Y, Qiu Y, Chen Q, Han X, Cai M, Hao L. Puerarin suppresses the hepatic gluconeogenesis via activation of PI3K\/Akt signaling pathway in diabetic rats and HepG(2) cells. Biomed Pharmacother. 2021;137:111325.","journal-title":"Biomed Pharmacother"},{"key":"1222_CR198","first-page":"2026","volume":"33","author":"W Sun","year":"2008","unstructured":"Sun W, Zheng X-z, Xu Q-l, Nian H, Liu G-l. Effects of puerarin on ADRP gene expression in fatty tissue of type 2 diabetes mellitus rats. Chin J Chin Materia Med. 2008;33:2026\u20138.","journal-title":"Chin J Chin Materia Med"},{"key":"1222_CR199","doi-asserted-by":"publisher","first-page":"9317","DOI":"10.3390\/ijms24119317","volume":"24","author":"Y Wen","year":"2023","unstructured":"Wen Y, Wang Y, Zhao C, Zhao B, Wang J. The pharmacological efficacy of baicalin in inflammatory diseases. Int J Mol Sci. 2023;24:9317.","journal-title":"Int J Mol Sci"},{"key":"1222_CR200","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1134\/S0036024424700584","volume":"98","author":"LN Xiong","year":"2024","unstructured":"Xiong LN. Theoretical investigation on molecular properties of baicalein (C15H10O5), the major component of traditional Chinese medicine scutellaria baicalensis georgi. Russ J Phys Chem A. 2024;98:1562\u201372.","journal-title":"Russ J Phys Chem A"},{"key":"1222_CR201","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1002\/ptr.7046","volume":"35","author":"V Baradaran Rahimi","year":"2021","unstructured":"Baradaran Rahimi V, Askari VR, Hosseinzadeh H. Promising influences of Scutellaria baicalensis and its two active constituents, baicalin, and baicalein, against metabolic syndrome: a review. Phytother Res. 2021;35:3558\u201374.","journal-title":"Phytother Res"},{"key":"1222_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115238","volume":"293","author":"X Yan","year":"2022","unstructured":"Yan X, Zhang Y, Peng Y, Li X. The water extract of Radix scutellariae, its total flavonoids and baicalin inhibited CYP7A1 expression, improved bile acid, and glycolipid metabolism in T2DM mice. J Ethnopharmacol. 2022;293:115238.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR203","volume":"95","author":"M Yu","year":"2021","unstructured":"Yu M, Han S, Wang M, Han L, Huang Y, Bo P, et al. Baicalin protects against insulin resistance and metabolic dysfunction through activation of GALR2\/GLUT4 signaling. Phytomedicine. 2021;95:153896.","journal-title":"Phytomedicine"},{"key":"1222_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153869","volume":"95","author":"M Yu","year":"2022","unstructured":"Yu M, Han S, Wang M, Han L, Huang Y, Bo P, et al. Baicalin protects against insulin resistance and metabolic dysfunction through activation of GALR2\/GLUT4 signaling. Phytomedicine. 2022;95:153869.","journal-title":"Phytomedicine"},{"key":"1222_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114663","volume":"283","author":"A Lum Nde","year":"2022","unstructured":"Lum Nde A, Chukwuma CI, Erukainure OL, Chukwuma MS, Matsabisa MG. Ethnobotanical, phytochemical, toxicology and anti-diabetic potential of Senna occidentalis (L.) link A review. J Ethnopharmacol. 2022;283:114663.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR206","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejphar.2019.04.027","volume":"854","author":"X Fan","year":"2019","unstructured":"Fan X, Zhang C, Niu S, Fan B, Gu D, Jiang K, et al. Ginsenoside Rg1 attenuates hepatic insulin resistance induced by high-fat and high-sugar by inhibiting inflammation. Eur J Pharmacol. 2019;854:247\u201355.","journal-title":"Eur J Pharmacol"},{"key":"1222_CR207","doi-asserted-by":"publisher","first-page":"gmr16019463","DOI":"10.4238\/gmr16019463","volume":"16","author":"W Tian","year":"2017","unstructured":"Tian W, Chen L, Zhang L, Wang B, Li XB, Fan KR, et al. Effects of ginsenoside Rg1 on glucose metabolism and liver injury in streptozotocin-induced type 2 diabetic rats. Genet Mol Res. 2017;16:gmr16019463.","journal-title":"Genet Mol Res"},{"key":"1222_CR208","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/ptr.3686","volume":"26","author":"HM Lee","year":"2012","unstructured":"Lee HM, Lee OH, Kim KJ, Lee BY. Ginsenoside Rg1 promotes glucose uptake through activated AMPK pathway in insulin-resistant muscle cells. Phytother Res. 2012;26:1017\u201322.","journal-title":"Phytother Res"},{"key":"1222_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106382","volume":"120","author":"H Su","year":"2024","unstructured":"Su H, Fan X, Tang Y, Wang S, Ma T, Shu B, et al. Molecular mechanism of ginsenoside Rg1 alleviating cognitive impairment in T2DM rats. J Funct Foods. 2024;120:106382.","journal-title":"J Funct Foods"},{"key":"1222_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109285","volume":"332","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhu H, Zhou W, Ye Q. Anti-inflammatory and anti-gouty-arthritic effect of free ginsenoside Rb1 and nano ginsenoside Rb1 against MSU induced gouty arthritis in experimental animals. Chem Biol Interact. 2020;332:109285.","journal-title":"Chem Biol Interact"},{"key":"1222_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105534","volume":"104","author":"W Wang","year":"2023","unstructured":"Wang W, Zhan W, Liang M, Huang Y, Liu Y, Wang L, et al. Ginsenoside Rb1 ameliorates the abnormal hepatic glucose metabolism by activating STAT3 in T2DM mice. J Funct Foods. 2023;104:105534.","journal-title":"J Funct Foods"},{"key":"1222_CR212","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.2147\/DMSO.S431423","volume":"16","author":"M Liang","year":"2023","unstructured":"Liang M, Zhan W, Wang L, Bei W, Wang W. Ginsenoside Rb1 promotes hepatic glycogen synthesis to ameliorate T2DM Through 15-PGDH\/PGE(2)\/EP4 signaling pathway. Diabet Metab Syndr Obes. 2023;16:3223\u201334.","journal-title":"Diabet Metab Syndr Obes"},{"key":"1222_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115997","volume":"303","author":"R Zhou","year":"2023","unstructured":"Zhou R, He D, Zhang H, Xie J, Zhang S, Tian X, et al. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles. J Ethnopharmacol. 2023;303:115997.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR214","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.3390\/molecules27072175","volume":"27","author":"B Xu","year":"2022","unstructured":"Xu B, Li Z, Zeng T, Zhan J, Wang S, Ho CT, et al. Bioactives of momordica charantia as potential anti-diabetic\/hypoglycemic agents. Molecules. 2022;27:2175.","journal-title":"Molecules"},{"key":"1222_CR215","first-page":"2594","volume":"35","author":"D Zhang","year":"2010","unstructured":"Zhang D, Nie X, Pan H, Yu L, Yang X, Xu J, et al. Study on effect of total saponins from Semen Nigellae on inflammatory mediators and ERK\/MAPK pathway in stimulated macrophage. Zhongguo Zhong Yao Za Zhi. 2010;35:2594\u20138.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1222_CR216","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejbt.2019.12.001","volume":"43","author":"S Jiang","year":"2020","unstructured":"Jiang S, Xu L, Xu Y, Guo Y, Wei L, Li X, et al. Anti-diabetic effect of Momordica charantia saponins in rats induced by high-fat diet combined with STZ. Electron J Biotechnol. 2020;43:41\u20137.","journal-title":"Electron J Biotechnol"},{"key":"1222_CR217","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.biopha.2018.09.098","volume":"109","author":"Q Wang","year":"2019","unstructured":"Wang Q, Wu X, Shi F, Liu Y. Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice. Biomed Pharmacother. 2019;109:744\u201350.","journal-title":"Biomed Pharmacother"},{"key":"1222_CR218","doi-asserted-by":"publisher","first-page":"1368950","DOI":"10.3389\/fphar.2024.1368950","volume":"15","author":"A Sun","year":"2024","unstructured":"Sun A, Yang H, Li T, Luo J, Zhou L, Chen R, et al. Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies. Front Pharmacol. 2024;15:1368950.","journal-title":"Front Pharmacol"},{"key":"1222_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2025.106539","volume":"183","author":"A Marchelak","year":"2025","unstructured":"Marchelak A, Gieleta M, Krasocka W, Magiera A. Berberis aristata DC (Indian barberry) Current insight into botanical, phytochemical, and pharmacological aspects, pharmacokinetics, safety of use and modern therapeutic applications. Fitoterapia. 2025;183:106539.","journal-title":"Fitoterapia"},{"key":"1222_CR220","doi-asserted-by":"publisher","first-page":"2074610","DOI":"10.1155\/2021\/2074610","volume":"2021","author":"J Guo","year":"2021","unstructured":"Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev. 2021;2021:2074610.","journal-title":"Oxid Med Cell Longev"},{"key":"1222_CR221","doi-asserted-by":"publisher","first-page":"1455534","DOI":"10.3389\/fphar.2024.1455534","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Bi C, Xi H, Wei F. Effects of administering berberine alone or in combination on type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol. 2024;15:1455534.","journal-title":"Front Pharmacol"},{"key":"1222_CR222","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1080\/13813455.2023.2258559","volume":"130","author":"M Araj-Khodaei","year":"2024","unstructured":"Araj-Khodaei M, Ayati MH, Azizi Zeinalhajlou A, Novinbahador T, Yousefi M, Shiri M, et al. Berberine-induced glucagon-like peptide-1 and its mechanism for controlling type 2 diabetes mellitus: a comprehensive pathway review. Arch Physiol Biochem. 2024;130:678\u201385.","journal-title":"Arch Physiol Biochem"},{"key":"1222_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116143","volume":"306","author":"C Tang","year":"2023","unstructured":"Tang C, Bao T, Zhang Q, Qi H, Huang Y, Zhang B, et al. Clinical potential and mechanistic insights of mulberry (Morus alba L.) leaves in managing type 2 diabetes mellitus: focusing on gut microbiota, inflammation, and metabolism. J Ethnopharmacol. 2023;306:116143.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR224","doi-asserted-by":"publisher","first-page":"1136772","DOI":"10.3389\/fphar.2023.1136772","volume":"14","author":"Z Liu","year":"2023","unstructured":"Liu Z, Feng Y, Zhao H, Hu J, Chen Y, Liu D, et al. Pharmacokinetics and tissue distribution of Ramulus Mori (Sangzhi) alkaloids in rats and its effects on liver enzyme activity. Front Pharmacol. 2023;14:1136772.","journal-title":"Front Pharmacol"},{"key":"1222_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114713","volume":"283","author":"JS Li","year":"2022","unstructured":"Li JS, Ji T, Su SL, Zhu Y, Chen XL, Shang EX, et al. Mulberry leaves ameliorate diabetes via regulating metabolic profiling and AGEs\/RAGE and p38 MAPK\/NF-\u03baB pathway. J Ethnopharmacol. 2022;283:114713.","journal-title":"J Ethnopharmacol"},{"key":"1222_CR226","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.3390\/nu14235050","volume":"14","author":"QW Sun","year":"2022","unstructured":"Sun QW, Lian CF, Chen YM, Ye J, Chen W, Gao Y, et al. Ramulus Mori (Sangzhi) alkaloids ameliorate obesity-linked adipose tissue metabolism and inflammation in mice. Nutrients. 2022;14:5050.","journal-title":"Nutrients"},{"key":"1222_CR227","doi-asserted-by":"publisher","first-page":"1272112","DOI":"10.3389\/fendo.2023.1272112","volume":"14","author":"Z Meng","year":"2023","unstructured":"Meng Z, Xu C, Liu H, Gao X, Li X, Lin W, et al. Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes. Front Endocrinol (Lausanne). 2023;14:1272112.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1222_CR228","doi-asserted-by":"publisher","first-page":"1334915","DOI":"10.3389\/fonc.2024.1334915","volume":"14","author":"Q Yang","year":"2024","unstructured":"Yang Q, Meng D, Zhang Q, Wang J. Advances in research on the anti-tumor mechanism of Astragalus polysaccharides. Front Oncol. 2024;14:1334915.","journal-title":"Front Oncol"},{"key":"1222_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104310","volume":"76","author":"Z-M Yang","year":"2020","unstructured":"Yang Z-M, Wang Y, Chen S-Y. Astragalus polysaccharide alleviates type 2 diabetic rats by reversing the glucose transporters and sweet taste receptors\/GLP-1\/GLP-1 receptor signaling pathways in the intestine-pancreatic axis. J Funct Foods. 2020;76:104310.","journal-title":"J Funct Foods"},{"key":"1222_CR230","first-page":"1617","volume":"17","author":"Z Wei","year":"2018","unstructured":"Wei Z, Weng S, Wang L, Mao Z. Mechanism of astragalus polysaccharides in attenuating insulin resistance in Rats with type 2 diabetes mellitus via the regulation of liver microRNA-203a-3p. Mol Med Rep. 2018;17:1617\u201324.","journal-title":"Mol Med Rep"},{"key":"1222_CR231","doi-asserted-by":"publisher","first-page":"11210","DOI":"10.1039\/D2FO02298B","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Chen C, Fu X. Hypoglycemic activity in vitro and vivo of a water-soluble polysaccharide from Astragalus membranaceus. Food Funct. 2022;13:11210\u201322.","journal-title":"Food Funct"},{"key":"1222_CR232","doi-asserted-by":"publisher","first-page":"10121","DOI":"10.1039\/D2FO02300H","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Chen C, Fu X. Hypoglycemic effect of the polysaccharides from Astragalus membranaceus on type 2 diabetic mice based on the \u201cgut microbiota-mucosal barrier.\u201d Food Funct. 2022;13:10121\u201333.","journal-title":"Food Funct"},{"key":"1222_CR233","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1081\/FRI-120023480","volume":"19","author":"Y Gao","year":"2003","unstructured":"Gao Y, Zhou S. Cancer prevention and treatment byganoderma, a mushroom with medicinal properties. Food Rev Int. 2003;19:275\u2013325.","journal-title":"Food Rev Int"},{"key":"1222_CR234","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.3390\/nu13082725","volume":"13","author":"E Seweryn","year":"2021","unstructured":"Seweryn E, Zia\u0142a A, Gamian A. Health-promoting of polysaccharides extracted from ganoderma lucidum. Nutrients. 2021;13:2725.","journal-title":"Nutrients"},{"key":"1222_CR235","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3892\/etm.2021.10252","volume":"22","author":"R Pan","year":"2021","unstructured":"Pan R, Lou J, Wei L. Significant effects of Ganoderma lucidum polysaccharide on lipid metabolism in diabetes may be associated with the activation of the FAM3C-HSF1-CAM signaling pathway. Exp Ther Med. 2021;22:820.","journal-title":"Exp Ther Med"},{"key":"1222_CR236","first-page":"339","volume":"35","author":"H Xue","year":"2010","unstructured":"Xue H, Qiao J, Meng G, Wu F, Luo J, Chen H, et al. Effect of Ganoderma lucidum polysaccharides on hemodynamic and antioxidation in T2DM rats. Zhongguo Zhong Yao Za Zhi. 2010;35:339\u201343.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1222_CR237","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ijbiomac.2019.11.047","volume":"155","author":"M Chen","year":"2020","unstructured":"Chen M, Xiao D, Liu W, Song Y, Zou B, Li L, et al. Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats. Int J Biol Macromol. 2020;155:890\u2013902.","journal-title":"Int J Biol Macromol"},{"key":"1222_CR238","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/1471-0307.12566","volume":"72","author":"E Yildiz","year":"2018","unstructured":"Yildiz E, Ozcan T. Functional and textural properties of vegetable-fibre enriched yoghurt. Int J Dairy Technol. 2018;72:199\u2013207","journal-title":"Int J Dairy Technol"},{"key":"1222_CR239","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.ijbiomac.2018.06.148","volume":"118","author":"L Chen","year":"2018","unstructured":"Chen L, Huang G. Extraction, characterization and antioxidant activities of pumpkin polysaccharide. Int J Biol Macromol. 2018;118:770\u20134.","journal-title":"Int J Biol Macromol"},{"key":"1222_CR240","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/molecules24050955","volume":"24","author":"X Chen","year":"2019","unstructured":"Chen X, Qian L, Wang B, Zhang Z, Liu H, Zhang Y, et al. Synergistic hypoglycemic effects of pumpkin polysaccharides and puerarin on type II diabetes mellitus mice. Molecules. 2019;24:955.","journal-title":"Molecules"},{"key":"1222_CR241","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13205-017-0843-1","volume":"7","author":"H Song","year":"2017","unstructured":"Song H, Sun Z. Hypolipidaemic and hypoglycaemic properties of pumpkin polysaccharides. 3 Biotech. 2017;7:159.","journal-title":"3 Biotech"},{"key":"1222_CR242","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200160","volume":"66","author":"Y Ti","year":"2022","unstructured":"Ti Y, Wang W, Wang X, Ban Y, Wang P, Zhang Y, et al. Pumpkin polysaccharide extracted by subcritical water: physicochemical characterization and anti-diabetic effects in T2DM rats. Mol Nutr Food Res. 2022;66:e2200160.","journal-title":"Mol Nutr Food Res"},{"key":"1222_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2021.112854","volume":"190","author":"RB Semwal","year":"2021","unstructured":"Semwal RB, Semwal DK, Combrinck S, Viljoen A. Emodin - a natural anthraquinone derivative with diverse pharmacological activities. Phytochemistry. 2021;190:112854.","journal-title":"Phytochemistry"},{"key":"1222_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.115122","volume":"223","author":"L Zhou","year":"2023","unstructured":"Zhou L, Hu X, Han C, Niu X, Han L, Yu H, et al. Comprehensive investigation on the metabolism of emodin both in vivo and in vitro. J Pharm Biomed Anal. 2023;223:115122.","journal-title":"J Pharm Biomed Anal"},{"key":"1222_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.11.018","volume":"59","author":"D Xiao","year":"2019","unstructured":"Xiao D, Hu Y, Fu Y, Wang R, Zhang H, Li M, et al. Emodin improves glucose metabolism by targeting microRNA-20b in insulin-resistant skeletal muscle. Phytomedicine. 2019;59:152758.","journal-title":"Phytomedicine"},{"key":"1222_CR246","doi-asserted-by":"publisher","first-page":"9696303","DOI":"10.1155\/2022\/9696303","volume":"2022","author":"L Han","year":"2022","unstructured":"Han L, Xi G, Guo N, Guo J, Rong Q. Expression and mechanism of TXNIP\/NLRP3 inflammasome in sciatic nerve of type 2 diabetic rats. Dis Markers. 2022;2022:9696303.","journal-title":"Dis Markers"},{"key":"1222_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109767","volume":"125","author":"DD Huang","year":"2020","unstructured":"Huang DD, Shi G, Jiang Y, Yao C, Zhu C. A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomed Pharmacother. 2020;125:109767.","journal-title":"Biomed Pharmacother"},{"key":"1222_CR248","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/molecules22071180","volume":"22","author":"CY Yonamine","year":"2017","unstructured":"Yonamine CY, Pinheiro-Machado E, Michalani ML, Alves-Wagner AB, Esteves JV, Freitas HS, et al. Resveratrol improves glycemic control in type 2 diabetic obese mice by regulating glucose transporter expression in skeletal muscle and liver. Molecules. 2017;22:1180.","journal-title":"Molecules"},{"key":"1222_CR249","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.3390\/ijms21144900","volume":"21","author":"DJ Den Hartogh","year":"2020","unstructured":"Den Hartogh DJ, Vlavcheski F, Giacca A, Tsiani E. Attenuation of free fatty acid (FFA)-induced skeletal muscle cell insulin resistance by resveratrol is linked to activation of AMPK and inhibition of mTOR and p70 S6K. Int J Mol Sci. 2020;21:4900.","journal-title":"Int J Mol Sci"},{"key":"1222_CR250","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.795980","volume":"13","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Wang Y, Han X, Fu S, Zhu C, Chen Q. Efficacy of resveratrol supplementation on glucose and lipid metabolism: a meta-analysis and systematic review. Front Physiol. 2022;13:795980.","journal-title":"Front Physiol"},{"key":"1222_CR251","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.3390\/molecules29122934","volume":"29","author":"Y Gu","year":"2024","unstructured":"Gu Y, Niu Q, Zhang Q, Zhao Y. Ameliorative effects of curcumin on type 2 diabetes mellitus. Molecules. 2024;29:2934.","journal-title":"Molecules"},{"key":"1222_CR252","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/ars.2008.2140","volume":"11","author":"SK Jain","year":"2009","unstructured":"Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal. 2009;11:241\u20139.","journal-title":"Antioxid Redox Signal"},{"key":"1222_CR253","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/aps.2017.92","volume":"39","author":"S Guo","year":"2018","unstructured":"Guo S, Meng XW, Yang XS, Liu XF, Ou-Yang CH, Liu C. Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes. Acta Pharmacol Sin. 2018;39:195\u2013204.","journal-title":"Acta Pharmacol Sin"},{"key":"1222_CR254","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22499","volume":"34","author":"ZH Xia","year":"2020","unstructured":"Xia ZH, Jiang X, Li K, Li LX, Chen WB, Wang YX, et al. Curcumin inhibits alloxan-induced pancreatic islet cell damage via antioxidation and antiapoptosis. J Biochem Mol Toxicol. 2020;34:e22499.","journal-title":"J Biochem Mol Toxicol"},{"key":"1222_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2020.104665","volume":"146","author":"T Yuan","year":"2020","unstructured":"Yuan T, Yin Z, Yan Z, Hao Q, Zeng J, Li L, et al. Tetrahydrocurcumin ameliorates diabetes profiles of db\/db mice by altering the composition of gut microbiota and up-regulating the expression of GLP-1 in the pancreas. Fitoterapia. 2020;146:104665.","journal-title":"Fitoterapia"},{"key":"1222_CR256","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMp2004889","volume":"383","author":"WH Chong","year":"2020","unstructured":"Chong WH, Yanoff LB, Andraca-Carrera E, Thanh HM. Assessing the safety of glucose-lowering drugs - a new focus for the FDA. N Engl J Med. 2020;383:1199\u2013202.","journal-title":"N Engl J Med"},{"key":"1222_CR257","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/S2213-8587(16)30380-1","volume":"4","author":"J Tian","year":"2016","unstructured":"Tian J, Lian F, Tong X. Safety and effectiveness of different herbal medicine dosage of Gegen Qinlian decoction in Chinese patients with type 2 diabetes: a double-blind, two-part, randomised controlled trial. Lancet Diabet Endocrinol. 2016;4:S25.","journal-title":"Lancet Diabet Endocrinol"},{"key":"1222_CR258","first-page":"275","volume":"16","author":"T Okamoto","year":"2005","unstructured":"Okamoto T. Safety of quercetin for clinical application (Review). Int J Mol Med. 2005;16:275\u20138.","journal-title":"Int J Mol Med"},{"key":"1222_CR259","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/cts.13063","volume":"14","author":"L Li","year":"2021","unstructured":"Li L, Gao H, Lou K, Luo H, Hao S, Yuan J, et al. Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: a single-center, randomized, double-blind, placebo-controlled multiple-ascending-dose study. Clin Transl Sci. 2021;14:2017\u201324.","journal-title":"Clin Transl Sci"},{"key":"1222_CR260","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020;11:5015.","journal-title":"Nat Commun"},{"key":"1222_CR261","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1210\/jc.2007-2404","volume":"93","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93:2559\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"1222_CR262","first-page":"1465","volume":"1","author":"MM Jeyaraman","year":"2020","unstructured":"Jeyaraman MM, Al-Yousif NSH, Singh Mann A, Dolinsky VW, Rabbani R, Zarychanski R, et al. Resveratrol for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020;1:1465\u2013858.","journal-title":"Cochrane Database Syst Rev"},{"key":"1222_CR263","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.2019.3471","volume":"321","author":"EW Gregg","year":"2019","unstructured":"Gregg EW, Hora I, Benoit SR. Resurgence in diabetes-related complications. JAMA. 2019;321:1867\u20138.","journal-title":"JAMA"},{"key":"1222_CR264","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/2211738510666211221165318","volume":"9","author":"S Albetawi","year":"2021","unstructured":"Albetawi S, Abdalhafez A, Abu-Zaid A. A review on recent controlled release strategies for oral drug delivery of repaglinide (a BCS Class II Drug). Pharm Nanotechnol. 2021;9:326\u201338.","journal-title":"Pharm Nanotechnol"},{"key":"1222_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154780","volume":"120","author":"A Arvind","year":"2021","unstructured":"Arvind A, Memel ZN, Philpotts LL, Zheng H, Corey KE, Simon TG. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: a meta-analysis. Metabolism. 2021;120:154780.","journal-title":"Metabolism"},{"key":"1222_CR266","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ajem.2022.03.023","volume":"56","author":"O Mehrpour","year":"2022","unstructured":"Mehrpour O, Saeedi F, Hoyte C, Hadianfar A, Nakhaee S, Brent J. Distinguishing characteristics of exposure to biguanide and sulfonylurea anti-diabetic medications in the United States. Am J Emerg Med. 2022;56:171\u20137.","journal-title":"Am J Emerg Med"},{"key":"1222_CR267","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11892-024-01539-1","volume":"24","author":"S Chaudhary","year":"2024","unstructured":"Chaudhary S, Kulkarni A. Metformin: past, present, and future. Curr Diab Rep. 2024;24:119\u201330.","journal-title":"Curr Diab Rep"},{"key":"1222_CR268","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.intimp.2017.11.040","volume":"55","author":"J Li","year":"2018","unstructured":"Li J, Bao L, Zha D, Zhang L, Gao P, Zhang J, et al. Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4\/p38-MAPK and TLR4\/NF-\u03baB signaling pathways. Int Immunopharmacol. 2018;55:9\u201319.","journal-title":"Int Immunopharmacol"},{"key":"1222_CR269","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1111\/1440-1681.13361","volume":"47","author":"O Azmy Nabeh","year":"2020","unstructured":"Azmy Nabeh O, Ishak Attallah M, El-Sayed E-G. The pivotal relation between glucagon-like peptides, NF\u03baB and inflammatory bowel disease. Clin Exp Pharmacol Physiol. 2020;47:1641\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1222_CR270","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.4155\/fmc-2021-0241","volume":"13","author":"W Wang","year":"2021","unstructured":"Wang W, Chen Z, Zheng T, Zhang M. Xanthohumol alleviates T2DM-induced liver steatosis and fibrosis by mediating the NRF2\/RAGE\/NF-\u03baB signaling pathway. Future Med Chem. 2021;13:2069\u201381.","journal-title":"Future Med Chem"},{"key":"1222_CR271","first-page":"298","volume":"13","author":"C Punziano","year":"2024","unstructured":"Punziano C, Trombetti S, Cesaro E, Grosso M, Faraonio R. Antioxidant systems as modulators of ferroptosis: focus on transcription factors. Antioxidants (Basel, Switzerland). 2024;13:298.","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"1222_CR272","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115544","volume":"168","author":"T Bao","year":"2023","unstructured":"Bao T, Zhang X, Xie W, Wang Y, Li X, Tang C, et al. Natural compounds efficacy in complicated diabetes: A new twist impacting ferroptosis. Biomed Pharmacother. 2023;168:115544.","journal-title":"Biomed Pharmacother"},{"key":"1222_CR273","doi-asserted-by":"publisher","first-page":"3906043","DOI":"10.1155\/2023\/3906043","volume":"2023","author":"Z Wei","year":"2023","unstructured":"Wei Z, Pinfang K, Jing Z, Zhuoya Y, Shaohuan Q, Chao S. Curcumin improves diabetic cardiomyopathy by inhibiting pyroptosis through AKT\/Nrf2\/ARE pathway. Mediators Inflamm. 2023;2023:3906043.","journal-title":"Mediators Inflamm"},{"key":"1222_CR274","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s12010-024-05075-2","volume":"197","author":"C Jia","year":"2025","unstructured":"Jia C, Zhao X, Song M, Sun X. Gynostemma pentaphyllum (Thunb) makino affects autophagy and improves diabetic peripheral neuropathy through txnip-mediated PI3K\/AKT\/mTOR signaling pathway. Appl Biochem Biotechnol. 2025;197:1209\u201324.","journal-title":"Appl Biochem Biotechnol"},{"key":"1222_CR275","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/cbin.11015","volume":"42","author":"W Zhou","year":"2018","unstructured":"Zhou W, Ye S. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy. Cell Biol Int. 2018;42:1282\u201391.","journal-title":"Cell Biol Int"},{"key":"1222_CR276","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12998\/wjcc.v12.i1.1","volume":"12","author":"TC Xu","year":"2024","unstructured":"Xu TC, Liu Y, Yu Z, Xu B. Gut-targeted therapies for type 2 diabetes mellitus: a review. World J Clin Cases. 2024;12:1\u20138.","journal-title":"World J Clin Cases"},{"key":"1222_CR277","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ctim.2015.11.005","volume":"24","author":"Y Hu","year":"2016","unstructured":"Hu Y, Zhou X, Liu P, Wang B, Duan DM, Guo DH. A comparison study of metformin only therapy and metformin combined with Chinese medicine jianyutangkang therapy in patients with type 2 diabetes: a randomized placebo-controlled double-blind study. Complement Ther Med. 2016;24:13\u20138.","journal-title":"Complement Ther Med"},{"key":"1222_CR278","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/ph16071020","volume":"16","author":"F Aghababaei","year":"2023","unstructured":"Aghababaei F, Hadidi M. Recent advances in potential health benefits of quercetin. Pharmaceuticals (Basel). 2023;16:1020.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1222_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2021.101983","volume":"33","author":"J Hussein","year":"2021","unstructured":"Hussein J, El-Naggar ME. Synthesis of an environmentally quercetin nanoemulsion to ameliorate diabetic-induced cardiotoxicity. Biocatal Agric Biotechnol. 2021;33:101983.","journal-title":"Biocatal Agric Biotechnol"},{"key":"1222_CR280","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ptr.7397","volume":"36","author":"J Chen","year":"2022","unstructured":"Chen J, Li G, Sun C, Peng F, Yu L, Chen Y, et al. Chemistry, pharmacokinetics, pharmacological activities, and toxicity of Quercitrin. Phytother Res. 2022;36:1545\u201375.","journal-title":"Phytother Res"},{"key":"1222_CR281","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/00498254.2010.529180","volume":"41","author":"X Zhang","year":"2011","unstructured":"Zhang X, Qiu F, Jiang J, Gao C, Tan Y. Intestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein. Xenobiotica. 2011;41:290\u20136.","journal-title":"Xenobiotica"},{"key":"1222_CR282","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3390\/pharmaceutics15112567","volume":"15","author":"J Solnier","year":"2023","unstructured":"Solnier J, Zhang Y, Kuo YC, Du M, Roh K, Gahler R, et al. Characterization and pharmacokinetic assessment of a new berberine formulation with enhanced absorption in vitro and in human volunteers. Pharmaceutics. 2023;15:2567.","journal-title":"Pharmaceutics"},{"key":"1222_CR283","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/13880209.2016.1255649","volume":"55","author":"Y Jia","year":"2017","unstructured":"Jia Y, Xu B, Xu J. Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats. Pharm Biol. 2017;55:510\u20135.","journal-title":"Pharm Biol"},{"key":"1222_CR284","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jgr.2024.03.004","volume":"48","author":"DT Nguyen","year":"2024","unstructured":"Nguyen DT, Kim MH, Baek MJ, Kang NW, Kim DD. Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides. J Ginseng Res. 2024;48:417\u201324.","journal-title":"J Ginseng Res"},{"key":"1222_CR285","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/molecules22030478","volume":"22","author":"W Liang","year":"2017","unstructured":"Liang W, Chen W, Wu L, Li S, Qi Q, Cui Y, et al. Quality evaluation and chemical markers screening of salvia miltiorrhiza bge (Danshen) based on HPLC fingerprints and HPLC-MS(n) coupled with chemometrics. Molecules. 2017;22:478.","journal-title":"Molecules"},{"key":"1222_CR286","first-page":"30051","volume":"S2210\u20138033","author":"BA Pendry","year":"2017","unstructured":"Pendry BA, Kemp V, Hughes MJ, Freeman J, Nuhu HK, Sanchez-Medina A, et al. Silymarin content in Silybum marianum extracts as a biomarker for the quality of commercial tinctures. J Herb Med. 2017;S2210\u20138033:30051\u20139.","journal-title":"J Herb Med"},{"key":"1222_CR287","doi-asserted-by":"publisher","first-page":"1534634","DOI":"10.3389\/fphar.2025.1534634","volume":"16","author":"M Li","year":"2025","unstructured":"Li M, Ding L, Cao L, Zhang Z, Li X, Li Z, et al. Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications. Front Pharmacol. 2025;16:1534634.","journal-title":"Front Pharmacol"},{"key":"1222_CR288","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005879","volume":"96","author":"ZJ Xu","year":"2017","unstructured":"Xu ZJ, Shu S, Li ZJ, Liu YM, Zhang RY, Zhang Y. Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-\u03b2\/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues. Medicine. 2017;96:e5879.","journal-title":"Medicine"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01222-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01222-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01222-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:02:18Z","timestamp":1759532538000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01222-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":288,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1222"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01222-x","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}